Regulatory (FoxP3(+)) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer

Antitumor immune responses induced by immune checkpoint inhibitors anti-PD-1 or anti-PD-L1 have been used as therapeutic strategies in advanced non-small cell lung cancer (NSCLC) patients over the last decade. Favorable antitumor activity to immune checkpoint inhibitors is correlated with high PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Jiae, Hur, Joon Young, Lee, Kyoung Young, Kim, Mi Soon, Heo, Jae Yeong, Ku, Bo Mi, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642363/
https://www.ncbi.nlm.nih.gov/pubmed/33149213
http://dx.doi.org/10.1038/s41598-020-76130-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642363/
https://www.ncbi.nlm.nih.gov/pubmed/33149213
http://dx.doi.org/10.1038/s41598-020-76130-1

Ejemplares similares